Should Free Thyroxine Go Back into the Routine Thyroid Profile?

 

 Buy Article Permissions and Reprints

Abstract

Background: Many clinical chemistry laboratories offer thyroid-stimulating hormone (TSH) alone as a first-line test of thyroid function, and only reflex a free thyroxine (fT4) test if the TSH result is abnormal (i. e., outside of the laboratory reference range). In secondary hypothyroidism, a low fT4 may be accompanied by a low or a normal TSH level. A testing strategy that measures baseline TSH only risks missing cases of secondary hypothyroidism in which the TSH level is normal.

Methods: The current authors examined 26 106 consecutive thyroid function test (TFT) results in our initial analysis. If the TFT results were compatible with hypopituitarism, with fT4 below the reference range (9–20 pmol/L) and a TSH result ≤5 mU/L (reference range: 0.5–5 mU/L), the laboratory performed further tests of pituitary function. The cost of identifying pituitary insufficiency by measuring both fT4 and TSH was estimated for our population (in 2004 and 2013) and compared with 2 other relevant studies.

Results: A total of 121 patients had a normal TSH with a low fT4. 8 new cases of secondary hypopituitarism were identified when fT4 was combined with TSH as the front-line TFT profile. Of these, 5 were found to have pituitary adenomas, 2 of which were macroprolactinomas. The reagent cost of identifying each case by inclusion of fT4 in the TFT profile decreased from £11 568 (€16 089) in 1998 to £1 451 (€2018) in 2013.

Conclusions: 8 cases of pituitary insufficiency would not have been identified with a strategy of TSH testing alone, which calls for the addition of fT4 to the routine TFT profile. The cost per case of identifying those with pituitary insufficiency by additional measurement of fT4 has become cheaper with time.

• References

• 1 Beckett GJ, Toft AD. First-line thyroid function tests – TSH alone is not enough. Clin Endocrinol 2003; 58: 20-21
  CrossrefPubMedGoogle Scholar
• 2 Caldwell G, Kellett HA, Gow SM et al. A new strategy for thyroid function testing. Lancet 1985; 1: 1117-1119
  PubMedGoogle Scholar
• 3 Wardle CA, Fraser WD, Squire CR. Pitfalls in the use of thyrotropin concentration as first line thyroid function tests. Lancet 2001; 357: 1013-1014
  CrossrefPubMedGoogle Scholar
• 4 Waise A, Belchetz PE. Clinical review: Lesson of the week. Unsuspected central hypothyroidism. Testing only for thyroid stimulating hormone will miss unsuspected cases of central hypothyroidism. BMJ 2000; 321: 1275-1277
  CrossrefPubMedGoogle Scholar
• 5 Ladenson PW, Singer PA, Ain KB et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000; 160: 1573-1575
  CrossrefPubMedGoogle Scholar
• 6 Association for Clinical Biochemistry; British Thyroid Association; British Thyroid Foundation . UK Guidelines for the Use of Thyroid Function Tests. July 2006 http://www.british-thyroid-association.org/info-for-patients/Docs/TFT_guideline_final_version_July_2006.pdf (Last updated: July 2006; Last accessed June 23, 2014)
  PubMedGoogle Scholar
• 7 Lamberts SWJ, de Herder WW, van der Lely AJ. Pituitary insufficiency. Lancet 1998; 352: 127-134
  CrossrefPubMedGoogle Scholar
• 8 Clayton RN, Wass JAH. Pituitary tumours: recommendations for service provision and guidelines for management of patients. London: Royal College of Physicians; 1997
  Google Scholar
• 9 Bauer DC, Brown AN. Sensitive thyrotropin and free thyroxine testing in outpatients. Are both necessary?. Arch Intern Med 1996; 156: 2333-2337
  CrossrefPubMedGoogle Scholar
• 10 Dayan CM. Interpretation of thyroid function tests. Lancet 2001; 357: 619-624
  CrossrefPubMedGoogle Scholar
• 11 Toft AD, Beckett GJ. Thyroid function tests and hypothyroidism: measurement of serum TSH alone may not always reflect thyroid status. BMJ 2003; 326: 295-296
  CrossrefPubMedGoogle Scholar
• 12 Goichot B, Perrin AE. Thyrotropin as first-line thyroid test. Lancet 2001; 358: 509
  CrossrefPubMedGoogle Scholar